Potential antiatherosclerotic drugs: novel N-substituted taurinamide derivatives.
Sapronov
Nikolay S
NS
Institute for Experimental Medicine of the Russian Academy of Medical Sciences, St-Petersburg, Russia 197376. nsn@iem.spb.ru
Khnychenko
Ludmila K
LK
Okunevich
Irina V
IV
Gavrovskaya
Ludmila K
LK
D017738:Alkanesulfonic Acids / Q000627:therapeutic use; D000577:Amides / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D000818:Animals; D050197:Atherosclerosis / Q000097:blood / Q000188:drug therapy*; D002791:Cholesterol, Dietary; D004032:Diet; D004487:Edema / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006168:Guinea Pigs; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood / Q000150:complications / Q000188:drug therapy; D008099:Liver / Q000737:chemistry; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013217:Starvation; D013654:Taurine / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use
D017738:Alkanesulfonic Acids; D000577:Amides; D002791:Cholesterol, Dietary; D005230:Fatty Acids, Nonesterified; C513229:N-(1-methyl-2-phenylethyl)aminoethane sulfonic acid isopropylamide; D013654:Taurine